SMI
13.136,27
PKT
+104,37
PKT
+0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 17.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 16.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 16.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Zurich Insurance Hold | Deutsche Bank AG | |
| 15.04.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 15.04.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 12.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 12.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.24 | Givaudan Hold | Deutsche Bank AG | |
| 12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.04.24 | Givaudan Sell | UBS AG | |
| 11.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | Givaudan Reduce | Baader Bank | |
| 11.04.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.24 | UBS Outperform | RBC Capital Markets | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG | |
| 09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Roche Equal Weight | Barclays Capital | |
| 08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
| 04.04.24 | UBS Outperform | RBC Capital Markets | |
| 03.04.24 | Swiss Re Sell | UBS AG | |
| 03.04.24 | Givaudan Sell | UBS AG | |
| 03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Givaudan Underweight | Barclays Capital | |
| 02.04.24 | Richemont Overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.